Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;10(12):2782-94.
doi: 10.3390/md10122782.

Antitumor effect of a polypeptide fraction from Arca subcrenata in vitro and in vivo

Affiliations

Antitumor effect of a polypeptide fraction from Arca subcrenata in vitro and in vivo

Xianjing Hu et al. Mar Drugs. 2012 Dec.

Abstract

Arca subcrenata Lischke is a marine traditional Chinese medicine. The study investigated the antitumor effects of P2, a polypeptide fraction from A. subcrenata, and its toxicity in vitro and in vivo. The results showed that P2 could inhibit the proliferation of seven tumor cell lines, especially in HeLa and HT-29 cell lines. The IC₅₀ values were 11.43 μg/mL for HeLa and 13.00 μg/mL for HT-29 treated by P2 for 48 h. P2 had little cytotoxicity on normal liver cells (L-02). The maximum tolerated dose (MTD) of P2 on KM mice was 1000 mg/kg by i.p. or i.v. The tumor growth inhibitory ratios of P2 were 26.4%, 41.4% and 46.4% for H-22, and 34.0%, 45.8% and 60.1% for S-180 tumor-bearing mice. The results demonstrated that P2 might be a potential antitumor agent with high efficiency in dose-dependent and time-dependent manners and low toxicity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of P2 on cell viability of human tumor cell lines. Seven tumor cell lines were treated by P2 at different concentrations for 48 h. Cell viability was determined by MTT assay. Data are presented as mean ± SD of three independent experiments.
Figure 2
Figure 2
Selective cytotoxicity effects of P2 on HeLa and HT-29 cells compared with normal liver L-02 cells. Data are presented as mean ± SD of three independent experiments.
Figure 3
Figure 3
Cytotoxicity of P2 on HeLa (A) and HT-29 (B) cells in a dose- and time-dependent manner. The IC50 was calculated according to the inhibition rate by Graph Pad software. Data are presented as mean ± SD of three independent experiments.
Figure 4
Figure 4
Cytotoxicity of P2 on cancer cells of HeLa and HT-29 and on normal liver L-02 cells.
Figure 5
Figure 5
Histopathologic analysis by H & E staining of five kinds of organs of P2-treated mice comparing with control mice (normal saline).
Figure 6
Figure 6
Antitumor effects of P2 against tumor growth on the S-180 (A) and H-22 (B) xenograft mice. Mice transplanted with S-180/H-22 cells were treated by P2 (7, 21, 63 mg/kg/day), CTX (25 mg/kg/day) or normal saline (10 mL/kg) for a consecutive nine days. Then the mice were sacrificed, and the tumors were excised. The images showed the tumor masses of mice treated by P2, CTX or normal saline.

Similar articles

Cited by

References

    1. Simmons T.L., Andrianasolo E., McPhail K., Flatt P., Gerwick W.H. Marine natural products as anticancer drugs. Mol. Cancer Ther. 2005;4:333–342. - PubMed
    1. Kumar N.S.S., Nazeer R.A., Jaiganesh R. Purification and identification of antioxidant peptides from the skin protein hydrolysate of two marine fishes, horse mackerel (Magalaspis cordyla) and croaker (Otolithes ruber) Amino Acids. 2012;42:1641–1649. doi: 10.1007/s00726-011-0858-6. - DOI - PubMed
    1. Wu S.C., Zhang Z.X. Scavenging effects of extracts of Scapharca subcrenata on oxygen free radical. Mod. Food Sci. Technol. 2010;26:238–240.
    1. Jiao G.L., Yu G.L., Wang W., Zhao X.L., Zhang J.Z., Ewart S.H. Properties of polysaccharides in several seaweeds from Atlantic Canada and their potential anti-influenza viral activities. J. Ocean Univ. China. 2012;11:205–212. doi: 10.1007/s11802-012-1906-x. - DOI
    1. Galeano E., Thomas O.P., Robledo S., Munoz D., Martinez A. Antiparasitic bromotyrosine derivatives from the marine sponge Verongula rigida. Mar. Drugs. 2011;9:1902–1913. doi: 10.3390/md9101902. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources